Recently, these medications have also been approved for weight loss, making them increasingly popular among those looking to shed excess pounds
At our practice in Montgomery County, Maryland, and through virtual care, these principles guide how we personalize diabetes, weight, lipid, and cardiometabolic care from multiple angles
Wegovy stands out for its superior weight reduction and cardioprotective effects compared to other antidiabetic medications
Two CVOTs of tirzepatide are being conducted: SURPASS-CVOT (NCT04255433), which is targeting individuals with T2D and a history of CVD
Probably nothing, since were all still getting older, and Protandim hasnt released any compelling evidence to the contrary
Given the relatively high level of gross Medicare Part D spending as of 2022 for the two semaglutide products combined, Ozempic and Rybelsus, its possible that Medicare could select this product for drug price negotiation as early as 2025, which would be just over seven years past its earliest FDA approval in late 2017